The Mesothelioma Center News – Page 6

• 

  Treatment & Doctors

  FDA Approves Keytruda for Certain Mesothelioma Patients

  Patients with pleural mesothelioma cancer may have another treatment option after the U.S. Food and Drug Administration approved the use of pembrolizumab for…

  

  Tim Povtak

  June 17, 2020
• 

  Research & Clinical Trials

  Study Finds Mesothelioma Therapies Underutilized in Women

  A multicenter research team of specialists has uncovered a surprising underutilization of treatments for pleural mesothelioma cancer in women. Clinical Lung Cancer recently…

  

  Tim Povtak

  June 15, 2020
• 

  Asbestos Exposure & Bans

  Major Cosmetic Companies Moving Away from Talc in Makeup

  Consumer concerns and the threat of potentially costly lawsuits are driving cosmetic companies away from the long-standing manufacture of talc-based products. Reuters News…

  

  Tim Povtak

  June 11, 2020
• 

  Research & Clinical Trials

  Ramucirumab Shows Promise in Mesothelioma Clinical Trial

  Patients with pleural mesothelioma cancer experienced a significant survival advantage when ramucirumab, a novel immunotherapy drug, was added to chemotherapy in…

  

  Tim Povtak

  June 9, 2020
• 

  Asbestos Exposure & Bans

  COVID-19 Closures Accelerate Asbestos Abatement in Schools

  The COVID-19 pandemic closed educational institutions everywhere, but it also opened a door to the acceleration of vitally important asbestos abatement in schools…

  

  Tim Povtak

  June 8, 2020
• 

  Asbestos Exposure & Bans

  Health Experts Criticize EPA’s Asbestos Draft Risk Evaluation

  Doctors, scientists and occupational health experts from across the country are openly criticizing the U.S. Environmental Protection Agency’s recent asbestos draft risk evaluation.

  

  Tim Povtak

  June 2, 2020
• 

  Research & Clinical Trials

  Durvalumab Phase III Trial Could Change Mesothelioma Care

  An international, much-anticipated phase III clinical trial that could change standard-of-care treatment for patients with malignant pleural mesothelioma will open soon, pending…

  

  Tim Povtak

  May 28, 2020
• 

  Treatment & Doctors

  Mesothelioma Specialist Brings HIPEC Expertise to Stanford

  Surgical oncologist and mesothelioma specialist Dr. Byrne Lee spent close to a decade in Southern California, building a well-respected peritoneal surface malignancy program…

  

  Tim Povtak

  May 26, 2020
• 

  Asbestos Exposure & Bans

  Johnson & Johnson Ends Talc-Based Baby Powder Sales in US, Canada

  Johnson & Johnson announced Tuesday that it will stop selling its iconic, talc-based baby powder, the target of thousands of lawsuits claiming that its…

  

  Tim Povtak

  May 20, 2020
• 

  Asbestos Exposure & Bans

  New Tests Find Asbestos-Contaminated Talc in Eyeshadow

  The Scientific Analytical Institute in Greensboro, North Carolina, recently uncovered asbestos-contaminated talc in two new eyeshadow makeup products sold online on sites like Amazon…

  

  Tim Povtak

  May 19, 2020